Honigblum Gregg R.
Known title: Chief Strategy OfficerCIK: 0001408053
Honigblum Gregg R.'s purchase track record
How the stock did after each of Honigblum Gregg R.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since April 22, 2025
Stock higher 6 months later
25%
3 months: 25%
Median 6-month return
-25.0%
3 months: -7.1%
Beat the S&P 500
25%
median -33.3% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/5/2025 | SINT | $290K | -32.5% | -49.6% | +7.5% |
| 11/7/2025 | SINT | $32K | -10.1% | -28.1% | +10.0% |
| 8/26/2025 | SINT | $185K | -4.1% | -21.9% | +6.6% |
| 4/22/2025 | SINT | $25K | +49.7% | +98.9% | +27.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SINT | ▲ Buy | Open Market | 3,200 | $14K | 12/8/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $21K | 12/8/2025 | View on chart |
| SINT | ▲ Buy | Grant | 53,867 | $0 | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $20K | 12/5/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $16K | 11/7/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $16K | 11/7/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $18K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $18K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $18K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $18K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $19K | 8/26/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 4,000 | $7K | 4/22/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 3,000 | $5K | 4/22/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 3,000 | $5K | 4/22/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 3,808 | $7K | 4/22/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 192 | $344 | 4/22/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SINTX Q3 Revenue Tops Guidance; Analyst Raises Target
SiNtx Technologies reported preliminary Q3 revenue of $2.2 million, significantly exceeding its previous guidance range of $0.9 million to $1.1 million. Following this update, Ascendiant Capital raised its price target to $12.50. This strong revenue performance stands out against the stock's 52-week range of $1.40 to $4.66.
SINTX Q3 Revenue Tops Guidance; Analyst Raises Target. SiNtx Technologies reported preliminary Q3 revenue of $2.2 million, significantly exceeding its previous guidance range of $0.9 million to $1.1 million. Following this update, Ascendiant Capital raised its price target to $12.50. This strong revenue performance stands out against the stock's 52-week range of $1.40 to $4.66.